Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia—A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study
Journal of Atherosclerosis and Thrombosis · 2025
DOI: 10.5551/jat.65001 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2025. Verfasst von Shizuya Yamashita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rinku General Medical Center. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Butyrates, Benzoxazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Rinku General Medical Center.
- Kikuchi Medical Association Hospital.
- Research Center for Health and Sports Sciences, Kumamoto Health Science University.
- National Center for Geriatrics and Gerontology.
- Chiba University.
- Global Clinical Development Department, Kowa Company Ltd.
Zitieren
APA
Yamashita, S., Araki, E., Arai, H., Yokote, K., Tanigawa, R., Saito, A., Suganami, H., Minamikawa, S., & Ishibashi, S. (2025). Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia—A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.65001
Vancouver
Yamashita S, Araki E, Arai H, Yokote K, Tanigawa R, Saito A, et al. Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia—A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study. Journal of Atherosclerosis and Thrombosis. 2025. doi:10.5551/jat.65001
BibTeX
@article{Yamashita2025,
author = {Yamashita, Shizuya and Araki, Eiichi and Arai, Hidenori and Yokote, Koutaro and Tanigawa, Ryohei and Saito, Ayumi and Suganami, Hideki and Minamikawa, Sara and Ishibashi, Shun},
title = {Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia—A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2025},
doi = {10.5551/jat.65001}
}
EUVIMED